9903.04.67: Section 232 Generic Pharmaceuticals at 0% Duty

Key Points

• 9903.04.67 is a Chapter 99 heading in the Pharmaceuticals 232 program for "generic pharmaceutical articles, as provided for in subdivision (c) of U.S. note 40 to this subchapter."
• The heading carries 0 percent additional duty: it is an exemption or claim heading, not a duty-bearing one.
• The legal authority in the facts is Proclamation 11020 (91 FR 18183) and U.S. note 40, with effect dates of July 31, 2026 for Annex III and September 29, 2026 for all companies.
• Whether your product qualifies turns on subdivision (c) of U.S. note 40 in the HTSUS, so read the note itself before you claim the heading.

On this page

1. What 9903.04.67 is
2. Scope and what the heading text says
3. Rate and effective dates
4. How it appears on an entry and stacks with other provisions
5. What importers should do
6. Key references

9903.04.67 is the Section 232 pharmaceuticals heading for generic pharmaceutical articles described in subdivision (c) of U.S. note 40. Importers of those articles need to know it, because it carries 0 percent additional duty. It is an exemption-style heading, not a charge. This article reflects the facts as of October 2026.

The links in this article go to the primary documents: the proclamations, Federal Register notices, and official tariff schedule pages themselves. Read the source.

What 9903.04.67 is

9903.04.67 sits in the Pharmaceuticals 232 program, created under Proclamation 11020 (91 FR 18183) and implemented in the Harmonized Tariff Schedule through U.S. note 40 to the relevant subchapter of Chapter 99. You can read the heading and the note on the USITC HTS site.

Within that program, some headings impose an additional duty and others exist so that an importer can identify goods that are exempt, excepted, or otherwise treated separately. 9903.04.67 is in the second group. It carries no additional duty on its own.

If you are comparing it with the duty-bearing pharma headings, see our related pieces on 9903.04.60, 9903.04.62, 9903.04.63, and 9903.04.64.

Scope and what the heading text says

The official heading

The heading reads: "Generic pharmaceutical articles, as provided for in subdivision (c) of U.S. note 40 to this subchapter." That is the entire scope statement we have for this code, and the article does not go beyond it.

What the heading does not say

• The heading text names no country. It does not limit the heading to a particular trading partner.
• The heading text names no onshoring-plan condition. Any conditions that apply sit in the note, not in the heading wording.

The definition of "generic pharmaceutical articles," the product boundaries, and any documentation or plan requirements are set out in subdivision (c) of U.S. note 40. Our facts do not reproduce that language, so confirm the current text in the HTSUS or with your broker. The same goes for any pricing or company-level mechanics tied to the note: send your team to the note itself rather than relying on a summary.

Rate and effective dates

The rate for 9903.04.67 is 0 percent additional duty. The legal authority reference for the heading lists two effective points: July 31, 2026 for Annex III, and September 29, 2026 for all companies. The rate and those windows belong together, so a 0 percent entry under this heading should be read against the date and company treatment the note provides.

The facts do not say how those two dates map to specific products or importers beyond the labels "Annex III" and "all companies." Check the annex and note text in the HTSUS before you decide which date governs a given entry.

The facts also do not state a end date for this heading. Do not assume one. Confirm status in the current HTSUS.

How it appears on an entry and stacks with other provisions

Chapter 99 rides alongside the regular line

A Chapter 99 heading is never reported alone. The product is still classified on its regular chapter 1 to 97 line, with its normal duty treatment. When the 9903.04.67 claim applies, the Chapter 99 number is reported in addition to that line. Because the additional duty is 0 percent, the Chapter 99 line adds nothing to the duty bill. It documents why the Section 232 pharma duty is not being assessed.

Interaction with other duties

Our facts do not address how this heading interacts with other tariff programs. Other duties that attach to the underlying product, such as the ordinary column 1 rate or measures under other programs, are governed by their own provisions. Review those separately. For background on related programs, see our 2026 tariff code overview and the explainer on reciprocal tariffs. For China-origin goods, the Section 301 list guide is the relevant reference. Whether any of those apply to your goods is an entry-level check, not something this heading answers.

Why a 0 percent claim still matters

• A wrong Chapter 99 number on an entry can trigger a correction or a protest, even where the duty is zero.
• If a product falls under a duty-bearing pharma heading instead of this one, underpayment exposure follows.
• If you filed under another heading before establishing eligibility, review whether a post-summary correction or a protest is available. The facts do not state a refund process for this code, so confirm with your broker.

What importers should do

• Read subdivision (c) of U.S. note 40 on the HTS site and match each product against its language before claiming 9903.04.67.
• Check the entry date against the July 31, 2026 (Annex III) and September 29, 2026 (all companies) effective points, and confirm which applies to your goods and your company.
• Have your broker report 9903.04.67 alongside the regular chapter 1 to 97 line, and keep the support for the generic classification in your entry file.
• Audit past pharma entries to confirm each carries the correct Section 232 pharma heading, whether this one or a duty-bearing one.

Key references

• Harmonized Tariff Schedule (USITC): the official text of heading 9903.04.67 and U.S. note 40, including subdivision (c).
• Federal Register: search here for Proclamation 11020, published at 91 FR 18183.
• White House: presidential actions page, for the proclamation text.
• U.S. Customs and Border Protection: CBP guidance and CSMS messages on Section 232 filing instructions.
• CustomsGenius 2026 tariff code overview: context on Chapter 99 programs.